Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Tianjin, China, 1991-1999 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Period approach, calendar period			Cohort approach, calendar period
Site	ICD-10	86-90	91-95	96-99	86-90	91-95	96-99
C01-02	Tongue	52.1	74.6	69.7	46.9	59.3	78.2
C01-02	Tongue	52.1	74.6	69.7	46.9	59.3	78.2
C03-06	Oral cavity	72.6	62.2	68.4	58.3	76.2	61.6
C03-06	Oral cavity	72.6	62.2	68.4	58.3	76.2	61.6
C07-08	Salivary gland	82.0	82.2	89.4	60.0	80.8	87.9
C07-08	Salivary gland	82.0	82.2	89.4	60.0	80.8	87.9
C11	Nasopharynx	57.5	57.3	59.2	44.6	64.1	54.0
C11	Nasopharynx	57.5	57.3	59.2	44.6	64.1	54.0
C32	Larynx	59.6	63.8	67.1	53.3	67.1	60.5
C32	Larynx	59.6	63.8	67.1	53.3	67.1	60.5
C37-38	Other thoracic organs	50.4	48.5	52.5	36.2	54.9	48.9
C37-38	Other thoracic organs	50.4	48.5	52.5	36.2	54.9	48.9
C43	Melanoma skin	62.1	75.2	58.3	51.9	68.8	67.5
C43	Melanoma skin	62.1	75.2	58.3	51.9	68.8	67.5
C44	Other skin	64.9	87.4	91.9	65.6	73.2	90.9
C44	Other skin	64.9	87.4	91.9	65.6	73.2	90.9
C53	Cervix	63.4	64.4	67.1	57.2	69.3	63.1
C53	Cervix	63.4	64.4	67.1	57.2	69.3	63.1
C54	Corpus uteri	85.5	93.3	91.8	73.1	91.0	91.3
C54	Corpus uteri	85.5	93.3	91.8	73.1	91.0	91.3
C56	Ovary	30.6	62.8	66.6	40.7	56.8	60.3
C56	Ovary	30.6	62.8	66.6	40.7	56.8	60.3
C64	Kidney	41.1	60.0	61.1	64.5	54.8	61.5
C64	Kidney	41.1	60.0	61.1	64.5	54.8	61.5
C67	Urinary bladder	62.4	74.7	74.9	56.4	69.7	73.9
C67	Urinary bladder	62.4	74.7	74.9	56.4	69.7	73.9
C82-85+C96	Non-Hodgkin lymphoma	48.7	49.9	49.8	42.1	54.3	45.6
C82-85+C96	Non-Hodgkin lymphoma	48.7	49.9	49.8	42.1	54.3	45.6
C90	Multiple myeloma	22.0	26.0	51.1	17.3	25.5	29.3
C90	Multiple myeloma	22.0	26.0	51.1	17.3	25.5	29.3

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Tianjin, China, 1991-1999 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1981-1990 and 1991-1999 (Tianjin, China)
- Table6:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Tianjin, China, 1991-1999 cases followed-up until 2000)

Registry chapter: